{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:42:22Z","timestamp":1792442542562,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00506","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T05:44:00Z","timestamp":1541483040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth"],"prefix":"10.3389","volume":"8","author":[{"given":"David J.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa M.","family":"Wasinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Dunleavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"St. Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Bann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMoa1716435","article-title":"Recurrent glioblastoma treated with recombinant poliovirus","volume":"379","author":"Desjardins","year":"2018","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/2326-6066.CIR-17-0314","article-title":"Improving CART-cell therapy of solid tumors with oncolytic virus-driven production of a bispecific T-cell engager","volume":"6","author":"Wing","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"St Croix","year":"2000","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1172\/JCI93472","article-title":"Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus","volume":"127","author":"Miles","year":"2017","journal-title":"J Clin Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","article-title":"TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)","volume":"64","author":"Nanda","year":"2004","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","article-title":"TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types","volume":"21","author":"Chaudhary","year":"2012","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1158\/0008-5472.CAN-09-1086","article-title":"Host-derived tumor endothelial marker 8 promotes the growth of melanoma","volume":"69","author":"Cullen","year":"2009","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1172\/JCI120481","article-title":"Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release","volume":"128","author":"Szot","year":"2018","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/OV.S96915","article-title":"Oncolytic Seneca Valley Virus: past perspectives and future directions","volume":"5","author":"Burke","year":"2016","journal-title":"Oncol Virother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/pbc.25269","article-title":"Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed\/refractory solid tumors: a report of the Children's Oncology Group","volume":"62","author":"Burke","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/jnci\/djm198","article-title":"Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers","volume":"99","author":"Reddy","year":"2007","journal-title":"J Natl Cancer Inst."},{"key":"B15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1158\/1078-0432.CCR-10-1706","article-title":"Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features","volume":"17","author":"Rudin","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14653240601048369","article-title":"Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag","volume":"9","author":"Felicetti","year":"2007","journal-title":"Cytotherapy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CJI.0b013e3181a1d134","article-title":"DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth","volume":"32","author":"Ruan","year":"2009","journal-title":"J Immunother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1158\/1538-7445.AM2016-2312","article-title":"TEM8\/ANTXR1 specific T cells co-target tumor stem cells and tumor vasculature in triple-negative breast cancer","volume":"76","author":"Byrd","year":"2017","journal-title":"Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3892\/ijo.29.5.1311","article-title":"Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance","volume":"29","author":"Davies","year":"2006","journal-title":"Int J Oncol."},{"key":"B20","first-page":"3417","article-title":"Tumor endothelial marker 8 expression in triple-negative breast cancer","volume":"31","author":"Gutwein","year":"2011","journal-title":"Anticancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"12424","DOI":"10.1073\/pnas.0905409106","article-title":"Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e13888","DOI":"10.1371\/journal.pone.0013888","article-title":"Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism","volume":"5","author":"Kintzer","year":"2010","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1158\/0008-5476.CAN-09-0725","article-title":"Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice","volume":"69","author":"Fernando","year":"2009","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mib.2004.12.005","article-title":"Interactions between anthrax toxin receptors and protective antigen","volume":"8","author":"Scobie","year":"2005","journal-title":"Curr Opin Microbiol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1242\/jcs.114.15.2755","article-title":"Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling","volume":"114","author":"Bell","year":"2001","journal-title":"J Cell Sci."},{"key":"B28","first-page":"6649","article-title":"Cell surface tumor endothelial markers are conserved in mice and humans","volume":"61","author":"Carson-Walter","year":"2001","journal-title":"Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e11203","DOI":"10.1371\/journal.pone.0011203","article-title":"The Structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin","volume":"5","author":"Sheng","year":"2010","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/toxins8020034","article-title":"Roles of anthrax toxin receptor 2 in anthrax toxin membrane insertion and pore formation","volume":"8","author":"Sun","year":"2016","journal-title":"Toxins"},{"key":"B33","doi-asserted-by":"publisher","first-page":"15861","DOI":"10.1038\/ncomms15861","article-title":"CMG2\/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome","volume":"8","author":"Burgi","year":"2017","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ajhg.2013.03.023","article-title":"Mutations in ANTXR1 cause GAPO syndrome","volume":"92","author":"Stranecky","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4161\/cc.20374","article-title":"Selective blockade of tumor angiogenesis","volume":"11","author":"Chaudhary","year":"2012","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1021\/mp500056d","article-title":"Immuno-PET imaging of tumor endothelial marker 8 (TEM8)","volume":"11","author":"Kuo","year":"2014","journal-title":"Mol Pharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1586\/era.12.164","article-title":"Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?","volume":"13","author":"Park","year":"2013","journal-title":"Expert Rev Anticancer Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/0008-5472.CAN-16-1911","article-title":"TEM8\/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer","volume":"78","author":"Byrd","year":"2018","journal-title":"Cancer Res."},{"key":"B39","first-page":"507","article-title":"Expression pattern of tumor endothelial marker 8 protein in gallbladder carcinomas","volume":"12","author":"Maurya","year":"2011","journal-title":"Asian Pac J Cancer Prev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-015-0688-5","article-title":"Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?","volume":"13","author":"Wagner","year":"2015","journal-title":"J Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/jnci\/djm132","article-title":"Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8","volume":"99","author":"Duan","year":"2007","journal-title":"J Natl Cancer Inst."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI121527","article-title":"Deadly DAaRTS destroy cancer cells via a tumor microenvironment-mediated trigger","volume":"128","author":"McCann","year":"2018","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yexcr.2004.12.025","article-title":"TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen","volume":"305","author":"Hotchkiss","year":"2005","journal-title":"Exp Cell Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"23227","DOI":"10.1074\/jbc.M603676200","article-title":"Anthrax toxin receptor 1\/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton","volume":"281","author":"Werner","year":"2006","journal-title":"J Biol Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.1985.tb51154.x","article-title":"Structure and macromolecular organization of type VI collagen","volume":"460","author":"Engel","year":"1985","journal-title":"Ann N Y Acad Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"16607","DOI":"10.1074\/jbc.M510192200","article-title":"The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells","volume":"281","author":"Lamande","year":"2006","journal-title":"J Biol Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/bbrc.2001.6227","article-title":"The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion","volume":"290","author":"Aigner","year":"2002","journal-title":"Biochem Biophys Res Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1432-1033.1994.00573.x","article-title":"Recombinant expression and properties of the Kunitz-type protease-inhibitor module from human type VI collagen alpha 3(VI) chain","volume":"225","author":"Mayer","year":"1994","journal-title":"Eur J Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI23424","article-title":"Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor\/stroma microenvironment","volume":"115","author":"Iyengar","year":"2005","journal-title":"J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1038\/ncomms4485","article-title":"Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction","volume":"5","author":"Sun","year":"2014","journal-title":"Nat Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.3390\/v9070170","article-title":"Update on senecavirus infection in Pigs","volume":"9","author":"Leme","year":"2017","journal-title":"Viruses"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e01927","DOI":"10.1128\/JVI.01927-17","article-title":"Cryo-EM structure of Seneca Valley Virus procapsid","volume":"92","author":"Strauss","year":"2017","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1073\/pnas.1500791112","article-title":"Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity","volume":"112","author":"LaFrance","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/pbc.22535","article-title":"Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program","volume":"55","author":"Morton","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/jnci\/djt130","article-title":"Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer","volume":"105","author":"Poirier","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/neuonc\/not065","article-title":"Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma","volume":"15","author":"Liu","year":"2013","journal-title":"Neuro Oncol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00506\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T10:37:02Z","timestamp":1662374222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00506\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":57,"alternative-id":["10.3389\/fonc.2018.00506"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00506","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"article-number":"506"}}